在质母细胞瘤中,KAT5调节与G0类群体相关的神经发育状态
Anca B Mihalas1, Sonali Arora1, Samantha A O'Connor2
1Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.
Nature communications
|May 9, 2025
概括
蛋白酸乙转移酶KAT5调节质母细胞瘤 (GBM) 细胞状态和自我更新. KAT5的失活减少了瘤的进展,并提高了生存率,突出了其在攻击性质瘤中的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 静止的癌症干细胞有助于瘤异质性和质母细胞瘤 (GBM) 的复发.
- 了解这些静止状态的调节者对于开发有效的GBM疗法至关重要.
研究的目的:
- 研究蛋白乙转移酶KAT5在调节GBM的转录,表观遗传和增殖异质性中的作用.
- 确定KAT5对GBM细胞过渡到G0类静止状态的影响及其对瘤进展和存活的影响.
主要方法:
- 在GBM类干细胞 (GSCs) 中分析KAT5的调节功能.
- 研究KAT5在E2F和MYC转录网络和蛋白质翻译中的作用.
- 评估KAT5失活后的瘤进展,侵入性行为和生存率.
- 在人类神经干细胞中对MYC表达进行实验,以评估KAT5活性和药物敏感性.
主要成果:
- 通过调节E2F和MYC网络,KAT5活动抑制静止的亚群,并促进GSC的自我更新.
- KAT5的失活显著降低了质母细胞瘤的进展和侵入性.
- 在标准护理治疗后,KAT5无活化导致生存率增加.
- 神经干细胞中MYC表达的增加模仿了类似于GSC的状态,增强了KAT5活性和药物敏感性.
结论:
- 凯特5是G0状态转换,神经发育类状态和质瘤中侵袭性瘤生长的关键调节者.
- 向KAT5可能通过破坏GSC自我更新并提高治疗疗效,为质母细胞瘤提供治疗策略.
更多相关视频
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
8.2K
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.4K
相关概念视频
01:04Glial Cells
85.6K
Overview
85.6K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K